Blog

Practical GLP-1 treatment tips from Gloe GLP-1

• Oral GLP-1: Wegovy pill clinical results, dosing, and availability

  June 22, 2026

  Once-daily oral semaglutide 25 mg (Wegovy pill). OASIS trial data, fasting protocol, dose titration, and FDA, MHRA, and EMA approval timelines by region.

  Read full article

• Retatrutide: Phase 3 results and global availability timeline

  June 21, 2026

  Triple GIP/GLP-1/glucagon agonist LY3437943 from Eli Lilly. Phase 3 TRIUMPH results, metabolic effects, and projected FDA, EMA, Japan, Korea, and Latin America timelines.

  Read full article

• Mounjaro reimbursement in France: BMI, HAS, and CSO pathway

  June 15, 2026

  Tirzepatide reimbursed at 65% from 15 June 2026. BMI criteria, HAS opinion, CSO or hospital prescription, supplementary insurance co-pay. What it means for GLP-1 tracking.

  Read full article

• Where does your GLP-1 data go? GDPR, US apps, and private cloud

  June 10, 2026

  Mounjaro doses, Ozempic weight, Wegovy side effects: health data under GDPR. Non-EU apps, US transfers, private iCloud. Gloe stores nothing on its servers.

  Read full article